A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
Clinical trial NCT05463965 · COMPLETED
Trial details
- NCT number
- NCT05463965
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2023-01-29
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.